SARS-CoV-2 Infection and CMV Dissemination in Transplant Recipients as a Treatment for Chagas Cardiomyopathy : A Case Report
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 has infected over 90 million people worldwide, therefore it is considered a pandemic. SARS-CoV-2 infection can lead to severe pneumonia, acute respiratory distress syndrome (ARDS), septic shock, and/or organ failure. Individuals receiving a heart transplantation (HT) may be at higher risk of adverse outcomes attributable to COVID-19 due to immunosuppressives, as well as concomitant infections that may also influence the prognoses. Herein, we describe the first report of two cases of HT recipients with concomitant infections by SARS-CoV-2, Trypanosoma cruzi, and cytomegalovirus (CMV) dissemination, from the first day of hospitalization due to COVID-19 in the intensive care unit (ICU) until the death of the patients.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:6 |
|---|---|
| Enthalten in: |
Tropical medicine and infectious disease - 6(2021), 1 vom: 10. Feb. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Gozzi-Silva, Sarah Cristina [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
CMV |
|---|
| Anmerkungen: |
Date Revised 31.03.2024 published: Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3390/tropicalmed6010022 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM321388380 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM321388380 | ||
| 003 | DE-627 | ||
| 005 | 20240331232520.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/tropicalmed6010022 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1358.xml |
| 035 | |a (DE-627)NLM321388380 | ||
| 035 | |a (NLM)33579042 | ||
| 035 | |a (PII)22 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Gozzi-Silva, Sarah Cristina |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a SARS-CoV-2 Infection and CMV Dissemination in Transplant Recipients as a Treatment for Chagas Cardiomyopathy |b A Case Report |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 31.03.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 has infected over 90 million people worldwide, therefore it is considered a pandemic. SARS-CoV-2 infection can lead to severe pneumonia, acute respiratory distress syndrome (ARDS), septic shock, and/or organ failure. Individuals receiving a heart transplantation (HT) may be at higher risk of adverse outcomes attributable to COVID-19 due to immunosuppressives, as well as concomitant infections that may also influence the prognoses. Herein, we describe the first report of two cases of HT recipients with concomitant infections by SARS-CoV-2, Trypanosoma cruzi, and cytomegalovirus (CMV) dissemination, from the first day of hospitalization due to COVID-19 in the intensive care unit (ICU) until the death of the patients | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a CMV | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Chagas disease | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a heart transplant | |
| 650 | 4 | |a infection | |
| 650 | 4 | |a severity | |
| 700 | 1 | |a Benard, Gil |e verfasserin |4 aut | |
| 700 | 1 | |a Alberca, Ricardo Wesley |e verfasserin |4 aut | |
| 700 | 1 | |a Yendo, Tatiana Mina |e verfasserin |4 aut | |
| 700 | 1 | |a Teixeira, Franciane Mouradian Emidio |e verfasserin |4 aut | |
| 700 | 1 | |a Oliveira, Luana de Mendonça |e verfasserin |4 aut | |
| 700 | 1 | |a Beserra, Danielle Rosa |e verfasserin |4 aut | |
| 700 | 1 | |a Pietrobon, Anna Julia |e verfasserin |4 aut | |
| 700 | 1 | |a Oliveira, Emily Araujo de |e verfasserin |4 aut | |
| 700 | 1 | |a Branco, Anna Cláudia Calvielli Castelo |e verfasserin |4 aut | |
| 700 | 1 | |a Andrade, Milena Mary de Souza |e verfasserin |4 aut | |
| 700 | 1 | |a Fernandes, Iara Grigoletto |e verfasserin |4 aut | |
| 700 | 1 | |a Pereira, Nátalli Zanete |e verfasserin |4 aut | |
| 700 | 1 | |a Ramos, Yasmim Álefe Leuzzi |e verfasserin |4 aut | |
| 700 | 1 | |a Lima, Julia Cataldo |e verfasserin |4 aut | |
| 700 | 1 | |a Provenci, Bruna |e verfasserin |4 aut | |
| 700 | 1 | |a Mangini, Sandrigo |e verfasserin |4 aut | |
| 700 | 1 | |a Duarte, Alberto José da Silva |e verfasserin |4 aut | |
| 700 | 1 | |a Sato, Maria Notomi |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Tropical medicine and infectious disease |d 2016 |g 6(2021), 1 vom: 10. Feb. |w (DE-627)NLM275181960 |x 2414-6366 |7 nnns |
| 773 | 1 | 8 | |g volume:6 |g year:2021 |g number:1 |g day:10 |g month:02 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/tropicalmed6010022 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 6 |j 2021 |e 1 |b 10 |c 02 | ||